Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.1650 USD | -11.58% |
|
-96.84% | -97.24% |
02-06 | BioXcel to Implement Reverse Stock Split; Shares Fall | MT |
02-05 | BioXcel Therapeutics Provides Clinical and Business Update | RE |
Executive Committee: BioXcel Therapeutics
Manager | Positions heldSince | ||||||
---|---|---|---|---|---|---|---|
Vimal Mehta 64 year |
| ||||||
Richard Steinhart 67 year |
| ||||||
Frank Yocca 69 year |
| ||||||
Vincent O'Neill 56 year |
| ||||||
Chetan Lathia |
| ||||||
Javier Rodriguez 53 year |
| ||||||
Brennan Doyle |
|
Composition of the Board of Directors: BioXcel Therapeutics
Director | CommitteesSince | ||||||||
---|---|---|---|---|---|---|---|---|---|
Peter Mueller 69 year |
| ||||||||
Michael Miller 68 year |
| ||||||||
Sandeep Laumas 57 year |
| ||||||||
June Bray 71 year |
| ||||||||
Michal Votruba 59 year |
| ||||||||
Rajiv Patni 56 year |
| ||||||||
David Mack 54 year |
| ||||||||
Vimal Mehta 64 year |
|
Latest Appointments: BioXcel Therapeutics
Former Officers and Directors: BioXcel Therapeutics
Insider | Positions held SinceUntil | ||||||
---|---|---|---|---|---|---|---|
| |||||||
| |||||||
| |||||||
| |||||||
| |||||||
| |||||||
| |||||||
| |||||||
| |||||||
|
Age distribution of managers
Parity Men Women
Male | 14 |
---|---|
Female | 1 |
Of which Executive Committee
Male | 7 |
---|---|
Female | 0 |
Of which Directors
Male | 7 |
---|---|
Female | 1 |
Revisions
ESG

MarketScreener is also available in this country: United States.
Switch edition